Our earlier study indicated that BMI1P1 is frequently down-regulated in AML patients and low-expressed BMI1P1 of AML patients had obviously shorter leukemia-free survival (LFS) and OS than high-expressed [19]. The gene discussed is BMI1P1; the disease is leukemia.